Structure of the catalytic domain of the hepatitis C virus NS2-3 protease
View abstract on PubMed
Summary
This summary is machine-generated.The Hepatitis C virus NS2-3 protease is a dimeric cysteine protease with unique composite active sites. This finding reveals new strategies for developing antiviral drugs against Hepatitis C virus infection.
Area Of Science
- Virology
- Structural Biology
- Biochemistry
Background
- Hepatitis C virus (HCV) poses a significant global health challenge, leading to cirrhosis and liver cancer.
- Current therapies for HCV are limited, and no vaccine is available.
- HCV polyprotein processing relies on two essential proteases: NS2-3 and NS3-4A.
Purpose Of The Study
- To resolve the enzymatic mechanism of the Hepatitis C virus NS2-3 protease.
- To determine the crystal structure of the NS2-3 protease catalytic domain.
Main Methods
- X-ray crystallography was used to determine the structure of the NS2-3 protease catalytic domain at 2.3 Å resolution.
- Analysis of the revealed dimeric structure and active site composition.
Main Results
- The NS2-3 protease functions as a dimeric cysteine protease.
- It features two composite active sites, with catalytic residues contributed by different monomers.
- The structure suggests an inactive post-cleavage conformation.
Conclusions
- The NS2-3 protease utilizes a novel mechanism involving composite active sites for polyprotein processing.
- This structural insight provides new avenues for designing targeted antiviral therapies against HCV.